Since we recently demonstrated that S1P3 is involved in the fibrotic and invasive traits of endometriotic cells [9, 10], the here presented data further support the potential of targeting S1P3 as a novel nonhormonal therapeutic strategy for endometriosis treatment. The gene discussed is S1PR3; the disease is endometriosis.